• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多结节性甲状腺肿与孤立性甲状腺结节相比患甲状腺癌的风险:600例患者的回顾性分析

The risk of thyroid carcinoma in multinodular goiter compared to solitary thyroid nodules: A retrospective analysis of 600 patients.

作者信息

Ajarma Khaled Y, Al-Faouri Ashraf F, Al Ruhaibeh Maysoon K, Almbaidien Feras A, Nserat Rima T, Al-Shawabkeh Abdallah O, Al-Sarihin Khaldon K, Al-Harazi Yousef A, Rbihat Haitham S, Aljbour Mohammad E

机构信息

Consultant (Surgery), King Hussein Medical Center, Amman 11831, Jordan.

Senior Specialist (Pathology), King Hussein Medical Center, Amman 11831, Jordan.

出版信息

Med J Armed Forces India. 2020 Jan;76(1):23-29. doi: 10.1016/j.mjafi.2018.05.001. Epub 2018 Jul 3.

DOI:10.1016/j.mjafi.2018.05.001
PMID:32020964
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6994747/
Abstract

BACKGROUND

It is generally believed that multinodular goiter (MNG) is associated with a lower risk of malignancy compared to solitary thyroid nodules (STN). This will be the null hypothesis in this retrospective study and we aim to prove or reject it.

METHODS

Medical files and histopathology reports of 600 patients who underwent thyroidectomy over 4-year period were reviewed. Data including patient' age, gender, presentation, ultrasonography, FNAC, surgical procedures, final histopathologic diagnosis and stage of malignant tumors were collected and analyzed. The primary end point was assessment of risk of thyroid carcinoma in patients with MNG compared to those with STN. Secondary endpoints included demographic differences and prognosis.

RESULTS

There were 459 females (76.5%). Mean age was 44.3 ± 14.5 years (range 14-85). After exclusion of 33 patients, 224 (39.5%) had STN and 343 (60.5%) had MNG. The prevalence of thyroid cancer was 41.1% (92/224) in STN compared to 29.2% (100/343) in MNG (Chi-Square = 8.593,  < 0.01). However, on multiple logistic regression analysis this correlation was found insignificant ( = 0.640). Only male gender ( = <0.000005) and preoperative impression of malignancy ( = 0.000082) were significantly associated with thyroid carcinoma.

CONCLUSION

The risk of thyroid carcinoma in STN and MNG was similar. Male gender was identified as a risk factor for thyroid cancer while age, number and size of nodules were not.

摘要

背景

人们普遍认为,与甲状腺单发结节(STN)相比,结节性甲状腺肿(MNG)的恶性风险较低。这将是本回顾性研究中的零假设,我们旨在证明或推翻它。

方法

回顾了600例在4年期间接受甲状腺切除术的患者的病历和组织病理学报告。收集并分析了包括患者年龄、性别、临床表现、超声检查、细针穿刺活检(FNAC)、手术方式、最终组织病理学诊断和恶性肿瘤分期等数据。主要终点是评估MNG患者与STN患者相比患甲状腺癌的风险。次要终点包括人口统计学差异和预后。

结果

有459名女性(76.5%)。平均年龄为44.3±14.5岁(范围14 - 85岁)。排除33例患者后,224例(39.5%)患有STN,343例(60.5%)患有MNG。STN中甲状腺癌的患病率为41.1%(92/224),而MNG中为29.2%(100/343)(卡方检验=8.593,P<0.01)。然而,在多因素逻辑回归分析中,发现这种相关性不显著(P = 0.640)。只有男性性别(P = <0.000005)和术前恶性肿瘤印象(P = 0.000082)与甲状腺癌显著相关。

结论

STN和MNG患甲状腺癌的风险相似。男性性别被确定为甲状腺癌的一个风险因素,而年龄、结节数量和大小则不是。

相似文献

1
The risk of thyroid carcinoma in multinodular goiter compared to solitary thyroid nodules: A retrospective analysis of 600 patients.多结节性甲状腺肿与孤立性甲状腺结节相比患甲状腺癌的风险:600例患者的回顾性分析
Med J Armed Forces India. 2020 Jan;76(1):23-29. doi: 10.1016/j.mjafi.2018.05.001. Epub 2018 Jul 3.
2
Thyroid Malignancy in Patients Who Underwent Thyroidectomy for Multinodular Goiter and Solitary Thyroid Nodule.因多结节性甲状腺肿和孤立性甲状腺结节接受甲状腺切除术患者的甲状腺恶性肿瘤
JCO Glob Oncol. 2024 May;10:e2300322. doi: 10.1200/GO.23.00322.
3
Nodule and cancer assessment following thyroid surgery: a cohort of 460 patients.甲状腺手术后结节和癌症评估:一项 460 例患者的队列研究。
Eur Rev Med Pharmacol Sci. 2020 Sep;24(18):9565-9570. doi: 10.26355/eurrev_202009_23042.
4
The value of Tc-99m tetrofosmin thyroid scintigraphy in patients with nodular goiter.锝-99m 替曲膦甲状腺闪烁扫描术在结节性甲状腺肿患者中的价值
Ann Nucl Med. 1997 Nov;11(4):285-90. doi: 10.1007/BF03165295.
5
Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?多结节性甲状腺肿手术治疗后的患者预后:多结节性是否会增加甲状腺恶性肿瘤的风险?
Medicine (Baltimore). 2016 Jul;95(28):e4194. doi: 10.1097/MD.0000000000004194.
6
Are there predictors of malignancy in patients with multinodular goiter?多结节性甲状腺肿患者的恶性肿瘤有预测因素吗?
J Surg Res. 2012 May 15;174(2):207-10. doi: 10.1016/j.jss.2011.11.1035. Epub 2011 Dec 20.
7
The Coexistence of Occult (Latent) Thyroid Cancer and Multinodular Goiter After Total Thyroidectomy: A Retrospective Study.全甲状腺切除术后隐匿性(潜伏性)甲状腺癌与多结节性甲状腺肿并存:一项回顾性研究
Cureus. 2024 Jun 14;16(6):e62386. doi: 10.7759/cureus.62386. eCollection 2024 Jun.
8
Need for an individualized and aggressive management of multinodular goiters of endemic zones by specially trained surgeons: experience in western Nepal.需要由经过专门培训的外科医生对地方性甲状腺肿流行地区的多结节性甲状腺肿进行个体化和积极的管理:尼泊尔西部的经验
World J Surg. 2006 Dec;30(12):2101-9; discussion 2110-1. doi: 10.1007/s00268-005-0346-9.
9
The use of fine-needle aspiration biopsy under ultrasound guidance to assess the risk of malignancy in patients with a multinodular goiter.在超声引导下使用细针穿刺活检来评估多结节性甲状腺肿患者的恶性风险。
Thyroid. 2000 Mar;10(3):235-41. doi: 10.1089/thy.2000.10.235.
10
Malignancy rate in nondominant nodules in patients with multinodular goiter: Experience with 1,606 cases evaluated by ultrasound-guided fine needle aspiration cytology.结节性甲状腺肿患者非优势结节的恶性率:1606例超声引导下细针穿刺细胞学评估经验
Cytojournal. 2011;8:19. doi: 10.4103/1742-6413.86970. Epub 2011 Oct 31.

引用本文的文献

1
Completion Thyroidectomy Trends and Rates: A Systematic Review and Meta-Analysis.甲状腺切除术的完成趋势与比率:一项系统评价和荟萃分析
Clin Otolaryngol. 2025 Mar;50(2):205-219. doi: 10.1111/coa.14262. Epub 2024 Nov 26.
2
Risk Factors for Malignancy in Patients with Multinodular Goiter.多结节性甲状腺肿患者发生恶性病变的危险因素
Int Arch Otorhinolaryngol. 2022 Jun 17;27(1):e138-e142. doi: 10.1055/s-0042-1748925. eCollection 2023 Jan.
3
Solitary and multiple thyroid nodules as predictors of malignancy: a systematic review and meta-analysis.孤立性和多发性甲状腺结节作为恶性肿瘤预测指标的系统评价与荟萃分析
Thyroid Res. 2022 Dec 5;15(1):22. doi: 10.1186/s13044-022-00140-6.
4
Incidentally discovered papillary thyroid microcarcinoma in patients undergoing thyroid surgery for benign disease.在因良性疾病接受甲状腺手术的患者中偶然发现甲状腺乳头状微小癌。
Endocrine. 2022 Aug;77(2):325-332. doi: 10.1007/s12020-022-03089-6. Epub 2022 May 31.

本文引用的文献

1
Thyroid nodule update on diagnosis and management.甲状腺结节诊断与管理的最新进展
Clin Diabetes Endocrinol. 2016 Oct 3;2:17. doi: 10.1186/s40842-016-0035-7. eCollection 2016.
2
Association between Hashimoto's Thyroiditis and Thyroid Cancer in 64,628 Patients.64628例患者中桥本甲状腺炎与甲状腺癌的关联
Front Oncol. 2017 Apr 10;7:53. doi: 10.3389/fonc.2017.00053. eCollection 2017.
3
Risk of Malignancy in Thyroid Nodules 4 cm or Larger.直径4厘米及以上甲状腺结节的恶变风险
Endocrinol Metab (Seoul). 2017 Mar;32(1):77-82. doi: 10.3803/EnM.2017.32.1.77. Epub 2017 Feb 6.
4
Patient outcomes following surgical management of multinodular goiter: Does multinodularity increase the risk of thyroid malignancy?多结节性甲状腺肿手术治疗后的患者预后:多结节性是否会增加甲状腺恶性肿瘤的风险?
Medicine (Baltimore). 2016 Jul;95(28):e4194. doi: 10.1097/MD.0000000000004194.
5
2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.2015年美国甲状腺协会成人甲状腺结节和分化型甲状腺癌管理指南:美国甲状腺协会甲状腺结节和分化型甲状腺癌指南工作组
Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.
6
Risk stratification of thyroid nodules on ultrasonography with the French TI-RADS: description and reflections.超声检查中甲状腺结节的风险分层:法国 TI-RADS 的描述和思考。
Ultrasonography. 2016 Jan;35(1):25-38. doi: 10.14366/usg.15027. Epub 2015 Jul 13.
7
Prevalence of goiter and thyroid nodules before and after implementation of the universal salt iodization program in mainland China from 1985 to 2014: a systematic review and meta-analysis.1985年至2014年中国大陆全民食盐加碘计划实施前后甲状腺肿和甲状腺结节的患病率:系统评价和荟萃分析
PLoS One. 2014 Oct 14;9(10):e109549. doi: 10.1371/journal.pone.0109549. eCollection 2014.
8
Thyroid cancer mortality and incidence: a global overview.甲状腺癌的死亡率和发病率:全球概述。
Int J Cancer. 2015 May 1;136(9):2187-95. doi: 10.1002/ijc.29251. Epub 2014 Oct 13.
9
Association of Hashimoto's thyroiditis with thyroid cancer.桥本甲状腺炎与甲状腺癌的关联。
Endocr Relat Cancer. 2014;21(6):845-52. doi: 10.1530/ERC-14-0258. Epub 2014 Sep 12.
10
Guidelines for the management of thyroid cancer.甲状腺癌管理指南。
Clin Endocrinol (Oxf). 2014 Jul;81 Suppl 1:1-122. doi: 10.1111/cen.12515.